
A global medical technology leader, Zimmer Biomet Holdings, Inc., released its participation in the American Orthopedic Foot and Ankle Society Annual Conference in Savannah, Ga. From September 10-13, 2025, Zimmer Biomet's wholly owned subsidiary, Paragon 28, will feature a suite of industry-leading foot and ankle products.
Featured technologies that will be showcased are:
- SMART 28℠ Case Management Portal featuring SMART Bun-Yo-Matic℠
- Provides an intuitive interface for case scheduling, direct communication with engineers, and conversion of surgical plans into patient-specific guides.
- APEX 3D S™ Stemmed Tibial Implant and Right-Angle Drill
- Expands the APEX 3D Total Ankle Replacement portfolio with a stemmed tibia implant. The 12mm stem and the smooth 9mm proximal were designed to address stress shielding; the 3mm distal features a lattice structure for immediate fixation at time of implantation.
- Phantom® Fibula Nail System
- Minimally invasive implant designed to help minimize soft tissue complications while providing fibula fracture stabilization.
- Features a proximal locking mechanism and syndesmotic fixation options.
- R3FLEX™ Stabilization System
- Next-generation syndesmotic repair solution that allows surgeons to dynamically adjust and visualize tension during fixation.
- Gorilla® Pilon Fusion Plating System
- Low-profile, anatomic dual-plating system with robust instrumentation designed for primary tibiotalar fusion in patients with unreconstructable pilon fractures.
- FJ2000™ Power Console and Burr System
- Sterile-packed, single-use power system designed for a wide range of foot and ankle procedures.
- PRECISION® MIS Bunion System
- Offers a minimally invasive solution for triplanar correction of bunions, for surgical precision and patient recovery.
Executive Statement
According to Albert DaCosta, Global President, Foot and Ankle, Zimmer Biomet, they are excited to engage with foot and ankle specialists at AOFAS and highlight their latest innovations in what's been a remarkably strong cadence of product launches over the past two years. Their continued progress is a direct reflection of their purpose to improve outcomes and experiences for patients suffering from foot and ankle conditions.
